SH Lee

3.6k total citations
164 papers, 2.4k citations indexed

About

SH Lee is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medicine and Surgery. According to data from OpenAlex, SH Lee has authored 164 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 31 papers in Emergency Medicine and 30 papers in Surgery. Recurrent topics in SH Lee's work include Lung Cancer Treatments and Mutations (27 papers), Emergency and Acute Care Studies (11 papers) and Cardiac Arrest and Resuscitation (11 papers). SH Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Emergency and Acute Care Studies (11 papers) and Cardiac Arrest and Resuscitation (11 papers). SH Lee collaborates with scholars based in South Korea, United States and Japan. SH Lee's co-authors include Changwoo Kang, Jin Hee Jeong, Seong Chun Kim, Dong Hoon Kim, Sang Bong Lee, Frank R. Brennan, Tibor T. Glant, Joshua J. Jacobs, B. M. Kwak and R. M. Urban and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

SH Lee

148 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SH Lee South Korea	28	596	485	351	315	281	164	2.4k
Chin‐Shang Li United States	41	663 1.1×	622 1.3×	504 1.4×	260 0.8×	327 1.2×	202	4.5k
Soyeon Ahn South Korea	33	1.1k 1.8×	630 1.3×	525 1.5×	574 1.8×	261 0.9×	162	3.6k
Tomoharu Shimizu Japan	30	588 1.0×	526 1.1×	535 1.5×	431 1.4×	498 1.8×	199	3.0k
Javier de la Cruz Spain	34	449 0.8×	540 1.1×	807 2.3×	169 0.5×	178 0.6×	195	3.7k
Irene Schmidtmann Germany	34	564 0.9×	498 1.0×	504 1.4×	366 1.2×	412 1.5×	265	4.1k
Liang Shen Singapore	36	882 1.5×	400 0.8×	676 1.9×	216 0.7×	480 1.7×	210	3.8k
Robert Parker United States	36	704 1.2×	572 1.2×	307 0.9×	392 1.2×	922 3.3×	140	4.2k
Jessica Barrett United Kingdom	23	657 1.1×	488 1.0×	412 1.2×	235 0.7×	330 1.2×	67	3.9k
Jacques S. Abramowicz United States	32	814 1.4×	389 0.8×	334 1.0×	151 0.5×	270 1.0×	215	3.9k
Wei Cheng China	28	488 0.8×	301 0.6×	438 1.2×	85 0.3×	267 1.0×	163	2.8k

Countries citing papers authored by SH Lee

Since Specialization

Citations

This map shows the geographic impact of SH Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SH Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SH Lee more than expected).

Fields of papers citing papers by SH Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SH Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SH Lee. The network helps show where SH Lee may publish in the future.

Co-authorship network of co-authors of SH Lee

This figure shows the co-authorship network connecting the top 25 collaborators of SH Lee. A scholar is included among the top collaborators of SH Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SH Lee. SH Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Yoon Jun, SH Lee, B. Liu, et al.. (2025). 4O: Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study. Journal of Thoracic Oncology. 20(3). S6–S8. 14 indexed citations

Psyrri, Amanda, Christophe Le Tourneau, Arunee Dechaphunkul, et al.. (2025). 1348MO SKYSCRAPER-09: Phase II, randomised study of tiragolumab (tira) + atezolizumab (atezo) and atezo + placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/metastatic PD-L1+ squamous cell carcinoma of the head and neck (R/M SCCHN). Annals of Oncology. 36. S776–S777.

Hong, Ming, Beatriz Cirauqui, J-P. Machiels, et al.. (2025). 1324MO ASPEN-04: A randomized phase II study of evorpacept in combination with pembrolizumab and chemotherapy in patients with recurrent, unresectable or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 36. S771–S771.

Shim, Bong Sup, et al.. (2025). LBA105 A phase II, open-label, single-arm, multi-center study of rivoceranib in patients with metastatic thymic epithelial tumor, KCSG LU23-09 (THRIVE). Annals of Oncology. 36. S1647–S1647.

Califano, Raffaele, SH Lee, Yuzhuo Wang, et al.. (2024). LBA54 Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutated, advanced non-small cell lung cancer after disease progression on osimertinib: Second interim overall survival from MARIPOSA-2. Annals of Oncology. 35. S1244–S1245. 6 indexed citations

Jones, David R., Moïshe Liberman, Terufumi Kato, et al.. (2024). OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC. Journal of Thoracic Oncology. 19(10). S8–S8. 5 indexed citations

Zhou, Caicun, Akira Ono, Hidetoshi Hayashi, et al.. (2024). 635P Cross-over adjusted overall survival for amivantamab plus chemotherapy vs chemotherapy in first-line EGFR exon-20 insertion NSCLC. Annals of Oncology. 35. S1638–S1639. 1 indexed citations

Passaro, Antonio, Byoung Chul Cho, Yan Wang, et al.. (2023). LBA15 Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial. Annals of Oncology. 34. S1307–S1307. 8 indexed citations

Lee, SH, et al.. (2023). Clinical characteristics and outcomes of injuries in agricultural and nonagricultural workers visiting the emergency department: a propensity-matched analysis. Clinical and Experimental Emergency Medicine. 11(1). 68–78.

10.

Lee, SH, et al.. (2023). Uncooperative patients suspected of acute stroke ineligible for prehospital stroke screening test by emergency medical service providers: final hospital diagnoses and characteristics. Clinical and Experimental Emergency Medicine. 10(2). 213–223. 1 indexed citations

11.

Kim, Dong Hoon, et al.. (2020). Initial Serum Ammonia as a Predictor of Mortality in Patients with Acute Glufosinate Ammonium Herbicide Poisoning. 18(2). 136–140.

12.

Lee, Sang Bong, Dong Hoon Kim, Taeyun Kim, et al.. (2019). Emergency Department Triage Early Warning Score (TREWS) predicts in-hospital mortality in the emergency department. The American Journal of Emergency Medicine. 38(2). 203–210. 37 indexed citations

13.

Kim, Dong Hoon, Changwoo Kang, SH Lee, et al.. (2019). Is the National Early Warning Score applicable to patients with trauma. Journal of the Korean society of emergency medicine. 30(6). 563–568. 2 indexed citations

14.

Lee, SH, et al.. (2018). Comparison of Economic and Clinical Outcomes Between Skin Staples Plus Wound Dressings and 2-Octyl Cyanoacrylate Plus Polymer Mesh Tape Among Patients Undergoing Cesarean Section. Value in Health. 21. S163–S163. 1 indexed citations

15.

Jeong, Jin Hee, Dong Hoon Kim, Taeyun Kim, et al.. (2018). Harmful effects of early hyperoxaemia in patients admitted to general wards: an observational cohort study in South Korea. BMJ Open. 8(10). e021758–e021758. 3 indexed citations

16.

Jeong, Jin Hee, Dong Hoon Kim, Seong Chun Kim, et al.. (2015). Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED. The American Journal of Emergency Medicine. 33(10). 1344–1349. 31 indexed citations

17.

Bai, Dingxi, et al.. (2008). A study on the reliability and the validity of Korean version of the Beck Depression Inventory-II (BDI-II). 14(2). 201–212. 148 indexed citations

18.

Ryu, Yon Ju, E. J. Kim, SH Lee, et al.. (2007). Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. European Respiratory Journal. 30(4). 736–742. 33 indexed citations

19.

Kim, Su-Jeong, et al.. (2001). Marginal Fitness and Marginal Leakage of Fiber-Reinforced Composite Crowns Depending upon Luting Cements. 45(106). 70. 1 indexed citations

20.

Lee, SH, et al.. (1996). INTRODUCTION OF SEARCHING AREA EXTRACTION SCHEME AND BI-DIRECTIONAL DIJKSTRA ALGORITHM FOR REDUCING SEARCH TIME OF THE SHORTEST PATH. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact